Immunic, Inc. (IMUX)
14.01
+1.04
(+8.02%)
USD |
NASDAQ |
May 27, 16:00
14.01
0.00 (0.00%)
After-Hours: 18:38
Immunic Shareholders Equity (Quarterly) : 151.23M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Sarepta Therapeutics, Inc. | 1.505B |
| ImmunityBio, Inc. | -870.01M |
| Mineralys Therapeutics, Inc. | 638.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.74M |
| Total Liabilities (Quarterly) | 38.51M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 4.920 |
| Net Debt Paydown Yield | 0.08% |